Corrigendum to “Elevated amyloid beta peptides and total tau in cerebrospinal fluid in individuals with Creatine transporter deficiency”

We would like to make a correction to Table 1.

Table 1.

CTD participant demographics, phenotype, and CSF biomarker levels. NW = no words; SW = single words; P = Phrases (i.e., uses multiple words together but not fluent speech). ABC = Vineland Adaptive Behavior Composite Score (population mean = 100, SD = 15). NVDQ = nonverbal developmental quotient from Mullen Scales of Early Learning (except where indicated). ^aCognitive test was a Weschler Abbreviated Scale of Intelligence.

ID	Sex	Age (yrs)	Seizure	Baseline Verbal Status	Baseline ABC	Baseline NVDQ	Tau (pg/ml)	Aβ42 (pg/ml)	Aβ40 (pg/ml)	Aβ42/ Aβ40	Pathological Variant	Protein Change
CD00028	M	7	no	NW	33	30.3	338.9	1560.6	17,808	0.088	c.1145C > T	p.P328L
CD00005	M	6.2	yes	SW	66	55a	139.3	442.9	5491.3	0.081	c912 + 36_913-18del35	Intron 5: 35 bp deletion
CD00004	M	10.2	yes	P	69	56 a	135	476.1	5961.4	0.080	c.859delC	p.1286wfsx22
CD00019	M	3.2	no	SW	65	47.1	300.6	1379.8	16,262.3	0.085	293 bp deletion of exon encompassing part of exon 10 and entire exon 11	N/A
CD00012	M	14.3	yes	P	36	51 a	224.1	941.1	11,098.5	0.085	c.1146_1150dup	p.L384RfxS14
CD00003	M	6.9	yes	SW	50	42	168.1	712.4	9538.1	0.075	c.321_323delCTT	p.F107del
CD00027	M	10.4	no	P	52	45 a	138.9	661.9	7801.3	0.085	unavailable	unavailable
CD00014	M	4.2	no	SW	62	61.9	202	964.1	11,004.9	0.088	c.1222_1224delTTC	p.F408del
CD00002	M	11	yes	NW	31	23.7	287.6	1278	14,226.2	0.090	c.1667G > A transition	p.Trp556X
CD00008	M	13.4	yes	NW	20	12.1	158	110.6	1459	0.076	c.1554G > A	p.W518X
CD00006	M	3.6	yes	NW	65	45.4	131	550.6	7032.8	0.078	c912 + 36_913-18del35	Intron 5: 35 bp deletion
CD00013	M	3.2	no	NW	55	23.2	195.3	982.3	10,991.8	0.089	c.1396G > A	p.G466R

The authors would like to apologize for any inconvenience caused.